Pivotal Bioventure Partners Fund I, L.p. - Net Worth and Insider Trading

Pivotal Bioventure Partners Fund I, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pivotal Bioventure Partners Fund I, L.p. owns 3 companies in total, including Inozyme Pharma Inc (INZY) , Akouos Inc (AKUS) , and Entasis Therapeutics Holdings Inc (ETTX) .

Click here to see the complete history of Pivotal Bioventure Partners Fund I, L.p.’s form 4 insider trades.

Insider Ownership Summary of Pivotal Bioventure Partners Fund I, L.p.

Ticker Comapny Transaction Date Type of Owner
INZY Inozyme Pharma Inc 2023-08-01 director
AKUS Akouos Inc 2020-06-25 10 percent owner
ETTX Entasis Therapeutics Holdings Inc 2018-09-25 10 percent owner

Pivotal Bioventure Partners Fund I, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Pivotal Bioventure Partners Fund I, L.p. Ownership Network

Ownership Network List of Pivotal Bioventure Partners Fund I, L.p.

No Data

Ownership Network Relation of Pivotal Bioventure Partners Fund I, L.p.

Insider Network Chart

Pivotal Bioventure Partners Fund I, L.p. Owned Company Details

What does Inozyme Pharma Inc do?

Who are the key executives at Inozyme Pharma Inc?

Pivotal Bioventure Partners Fund I, L.p. is the director of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .

Inozyme Pharma Inc (INZY) Insider Trades Summary

Over the past 18 months, Pivotal Bioventure Partners Fund I, L.p. made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 7,523 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 7,523 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inozyme Pharma Inc Insider Transactions

No Available Data

Pivotal Bioventure Partners Fund I, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Pivotal Bioventure Partners Fund I, L.p.. You might contact Pivotal Bioventure Partners Fund I, L.p. via mailing address: 501 Second Street, Suite 200, San Francisco Ca 94107.

Discussions on Pivotal Bioventure Partners Fund I, L.p.

No discussions yet.